Scholar Rock Holding annual net profit margin
2019
2020
2021
2022
Scholar Rock Holding Net Profit Margin Growth & History (SRRK)
Scholar Rock Holding's net profit margin was −405.21% for fiscal 2022.
View full Scholar Rock Holding company overviewScholar Rock Holding annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −405.21% | +295.25 pp |
| 2021 | 2021-12-31 | −700.46% | −138.99 pp |
| 2020 | 2020-12-31 | −561.47% | −312.59 pp |
| 2019 | 2019-12-31 | −248.88% | — |
Scholar Rock Holding quarterly net profit margin
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2022 | 2022-03-31 | −23.95% | +563.79 pp |
| Q4 2021 | 2021-12-31 | −886.98% | −113.67 pp |
| Q3 2021 | 2021-09-30 | −686.44% | +89.36 pp |
| Q2 2021 | 2021-06-30 | −668.27% | −173.89 pp |
| Q1 2021 | 2021-03-31 | −587.74% | −248.38 pp |
| Q4 2020 | 2020-12-31 | −773.31% | −620.49 pp |
| Q3 2020 | 2020-09-30 | −775.80% | −437.57 pp |
| Q2 2020 | 2020-06-30 | −494.38% | −245.82 pp |
| Q1 2020 | 2020-03-31 | −339.36% | +6.90 pp |
| Q4 2019 | 2019-12-31 | −152.82% | — |
| Q3 2019 | 2019-09-30 | −338.23% | — |
| Q2 2019 | 2019-06-30 | −248.56% | — |
| Q1 2019 | 2019-03-31 | −346.27% | — |
Scholar Rock Holding net profit margin trends
Between the periods ended 2019-12-31 and 2022-12-31, Scholar Rock Holding's net profit margin decreased from −248.88% to −405.21%, a change of −156.33 percentage points. The latest reported quarter, Q1 2022, shows −23.95%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scholar Rock Holding source filings ↗Community posts
Scholar Rock wins FDA approval for muscle-targeted SMA treatment
Scholar Rock ($SRRK) received FDA approval for ISEMBYLD, its apitegromab treatment for spinal muscular atrophy, in patients aged two and older receiving SMN2-targeted therapy. The company plans to begin shipping the medicine within days. Th ...